It is such an important element of our trials that will provide mountains of critical evidence especially relating to Zilosul as a DMOAD.
The best part is we get the results this year. I am unsure if we get updates on the other secondary outcomes as well, especially the ones that mirror 002. Good results will be significantly market sensitive.
Thanks for sharing RTheo.
PAR Price at posting:
$2.65 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)